Diabetes mellitus T2DM (Type2)

Prediabetes: prevalent and preventable but underdiagnosed and undertreated.
[19127764] Manag Care 17(12): 33-4, 40 (2008)

Redefining the role of thiazolidinediones in the management of type 2 diabetes.
[19436665] Vasc Health Risk Manag 5(1): 141-51 (2009)

Optimizing combination treatment in the management of type 2 diabetes.
[18078018] Vasc Health Risk Manag 3(5): 665-71 (2007)

Self-monitoring of blood glucose in type 2 diabetes: systematic review.
[20226138] Health Technol Assess 14(12): 1-140 (2010)

The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review.
[18405469] Health Technol Assess 12(9): 1-116, iii (2008)

Cost-effectiveness of insulin analogs.
[18999911] Am J Manag Care 14(11): 766-75 (2008)

Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
[18197742] Am J Manag Care 14(1): 25-30 (2008)

A systematic review of diabetes disease management programs.
[15839184] Am J Manag Care 11(4): 242-50 (2005)

Prevention of the complications of diabetes.
[12653455] Am J Manag Care 9(3 Suppl): S63-80; quiz S81-4 (2003)

Current treatment approaches to type 2 diabetes mellitus: successes and shortcomings.
[12408409] Am J Manag Care 8(16 Suppl): S460-71 (2002)

Diabetes management: current diagnostic criteria, drug therapies, and state legislation.
[10178463] Am J Manag Care 3(10): 1599-608; quiz 1161-4 (1997)

Manifestations of diabetes mellitus--their possible relationships to an underlying cell defect. A review.
[4596653] Am J Pathol 75(1): 204-24 (1974)

Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.
[18794553] Ann Intern Med 149(8): 549-59 (2008)

Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.
[17638715] Ann Intern Med 147(6): 386-99 (2007)

Narrative review: a rational approach to starting insulin therapy.
[16847295] Ann Intern Med 145(2): 125-34 (2006)

The biochemistry of diabetes.
[3291853] Biochem J 250(3): 625-40 (1988)

DIABETES MELLITUS. A REVIEW OF SOME RECENT INVESTIGATIONS INTO THE NATURE OF THE CLINICAL SYNDROME.
[14106540] Calif Med 100(-): 1-9 (1964)

Diagnosis and classification of diabetes mellitus.
[15618111] Diabetes Care 28 Suppl 1(-): S37-42 (2005)

Diagnosis and classification of diabetes mellitus.
[14693921] Diabetes Care 27 Suppl 1(-): S5-S10 (2004)

Pharmacologic treatment of type 2 diabetes.
[12547894] Diabetes Care 26(2): 526-33 (2003)

Report of the expert committee on the diagnosis and classification of diabetes mellitus.
[12502614] Diabetes Care 26 Suppl 1(-): S5-20 (2003)

Standards of medical care for patients with diabetes mellitus.
[11772918] Diabetes Care 25(1): 213-29 (2002)

Postprandial hyperglycaemia: to treat or not to treat?
[16735958] Diabetes Metab 32(2): 105-11 (2006)

Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities.
[16523182] Diabetes Metab 32(1): 7-13 (2006)

Use of antidiabetic drugs in elderly patients.
[16415772] Diabetes Metab 31 Spec No 2(-): 5S98-5S104 (2005)

An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives.
[15959415] Diabetes Metab 31(2): 101-9 (2005)

Clinical review: the genetics of type 2 diabetes: a realistic appraisal in 2008.
[18782870] J Clin Endocrinol Metab 93(12): 4633-42 (2008)

Approach to the patient with prediabetes.
[18772457] J Clin Endocrinol Metab 93(9): 3259-65 (2008)

A new look at screening and diagnosing diabetes mellitus.
[18460560] J Clin Endocrinol Metab 93(7): 2447-53 (2008)

Clinical review 146: The impact of clinical trials on the treatment of diabetes mellitus.
[11994319] J Clin Endocrinol Metab 87(5): 1929-37 (2002)

Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.
[11549624] J Clin Endocrinol Metab 86(9): 4047-58 (2001)

Clinical review 102: Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment.
[10199747] J Clin Endocrinol Metab 84(4): 1165-71 (1999)

Islet beta cell failure in type 2 diabetes.
[16823478] J Clin Invest 116(7): 1802-12 (2006)

Lipoprotein metabolism in diabetes mellitus.
[3302085] J Lipid Res 28(6): 613-28 (1987)

Insulin glargine: a long acting insulin analog.
[15793346] J Postgrad Med 51(1): 68-71 (2005)

Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin.
[12683698] Mayo Clin Proc 78(4): 459-67 (2003)

Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus.
[12683697] Mayo Clin Proc 78(4): 447-56 (2003)

New concepts in diabetes mellitus. II: Complications.
[7937425] Postgrad Med J 70(825): 479-85 (1994)

New concepts in diabetes mellitus. I: Treatment, pregnancy and aetiology.
[8029161] Postgrad Med J 70(824): 418-27 (1994)

Polyamines in clinical disorders.
[3976221] West J Med 142(1): 63-73 (1985)

Cost-effectiveness of insulin analogues for diabetes mellitus.
[19221353] CMAJ 180(4): 400-7 (2009)

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.
[19221352] CMAJ 180(4): 385-97 (2009)

Efficacy of intensive multitherapy for patients with type 2 diabetes mellitus: a randomized controlled trial.
[16293781] CMAJ 173(12): 1457-66 (2005)

Non-insulin-dependent (type II) diabetes mellitus.
[1742694] CMAJ 145(12): 1571-81 (1991)

Starting insulin therapy for type-2 diabetes.
[20513939] Acta Med Indones 42(2): 116-20 (2010)

Alternative therapies for type 2 diabetes.
[11896745] Altern Med Rev 7(1): 45-58 (2002)

The effects of biofeedback in diabetes and essential hypertension.
[20622080] Cleve Clin J Med 77 Suppl 3(-): S68-71 (2010)

Insulin treatment for type 2 diabetes: when to start, which to use.
[21536829] Cleve Clin J Med 78(5): 332-42 (2011)

How to manage type 2 diabetes in medical and surgical patients in the hospital.
[21632909] Cleve Clin J Med 78(6): 379-84 (2011)

Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.
[19952298] Cleve Clin J Med 76 Suppl 5(-): S12-9 (2009)

Redefining treatment success in type 2 diabetes mellitus: Comprehensive targeting of core defects.
[19952302] Cleve Clin J Med 76 Suppl 5(-): S39-47 (2009)

Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus.
[19952303] Cleve Clin J Med 76 Suppl 5(-): S4-11 (2009)

Managing diabetes in hemodialysis patients: observations and recommendations.
[19884294] Cleve Clin J Med 76(11): 649-55 (2009)

Strategies for optimizing glycemic control and cardiovascular prognosis in patients with type 2 diabetes mellitus.
[21270290] Mayo Clin Proc 86(2): 128-38 (2011)

Defining and achieving treatment success in patients with type 2 diabetes mellitus.
[21106864] Mayo Clin Proc 85(12 Suppl): S50-9 (2010)

Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?
[19015168] Nephrol Dial Transplant 24(2): 338-41 (2009)

Management of progressive type 2 diabetes: role of insulin therapy.
[19573240] Osteopath Med Prim Care 3(-): 5 (2009)

Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus.
[20739389] J Clin Endocrinol Metab 95(9): 4206-16 (2010)

Update on nonautoimmune diabetes in children.
[19584196] J Clin Endocrinol Metab 94(7): 2215-20 (2009)

Insights into molecular pathogenesis of type 2 diabetes from knockout mouse models.
[12201207] Endocr J 49(3): 247-63 (2002)

Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of type 2 diabetes [Review].
[21908934] Endocr J 58(10): 819-25 (2011)

Genetics of type 2 diabetes: the GWAS era and future perspectives [Review].
[21778616] Endocr J 58(9): 723-39 (2011)

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
[17613449] Endocr Pract 13 Suppl 1(-): 1-68 (2007)

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
[19858063] Endocr Pract 15(6): 540-59 (2009)

The role of mitochondria in the pathogenesis of type 2 diabetes.
[20156986] Endocr Rev 31(3): 364-95 (2010)

Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.
[18314421] Endocr Rev 29(3): 303-16 (2008)

Syndromes of ketosis-prone diabetes mellitus.
[18292467] Endocr Rev 29(3): 292-302 (2008)

Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins.
[18292465] Endocr Rev 29(3): 367-79 (2008)

The role for endoplasmic reticulum stress in diabetes mellitus.
[18048764] Endocr Rev 29(1): 42-61 (2008)

The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes.
[18436705] Endocr Rev 29(3): 317-33 (2008)

Pathomechanisms of type 2 diabetes genes.
[19749172] Endocr Rev 30(6): 557-85 (2009)

A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors.
[21447284] Discov Med 11(58): 255-63 (2011)

Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon.
[19466209] Arq Bras Endocrinol Metabol 53(2): 165-74 (2009)

Type 2 diabetes mellitus--guidelines for initiating insulin therapy.
[17619673] Aust Fam Physician 36(7): 549-53 (2007)

Animal models in type 2 diabetes research: an overview.
[17496368] Indian J Med Res 125(3): 451-72 (2007)

The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.
[18772488] J Androl 30(1): 23-32 (2009)

Complementary and alternative medicine for the treatment of type 2 diabetes.
[19509199] Can Fam Physician 55(6): 591-6 (2009)

Targeting the AMPK pathway for the treatment of Type 2 diabetes.
[19273282] Front Biosci 14(-): 3380-400 (2009)

Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes.
[19273250] Front Biosci 14(-): 2983-95 (2009)

New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies.
[18309002] Clin J Am Soc Nephrol 3 Suppl 2(-): S38-48 (2008)

Ketosis-prone type 2 diabetes: time to revise the classification of diabetes.
[17130220] Diabetes Care 29(12): 2755-7 (2006)

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.
[15616251] Diabetes Care 28(1): 154-63 (2005)

Pediatric endocrinologists' management of children with type 2 diabetes.
[20007947] Diabetes Care 33(3): 512-4 (2010)

Islet inflammation in type 2 diabetes: from metabolic stress to therapy.
[18227479] Diabetes Care 31 Suppl 2(-): S161-4 (2008)

Current views on type 2 diabetes.
[19770178] J Endocrinol 204(1): 1-11 (2010)

Liraglutide in the management of type 2 diabetes.
[21116334] Drug Des Devel Ther 4(-): 279-90 (2010)

Epigenetic mechanisms in the development of type 2 diabetes.
[19864158] Trends Endocrinol Metab 21(4): 223-9 (2010)

Sulfonylurea receptor -1 (SUR1): genetic and metabolic evidences for a role in the susceptibility to type 2 diabetes mellitus.
[11938023] Diabetes Metab 28(1): 14-9 (2002)

Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia.
[21211733] Diabetes Metab 36 Suppl 3(-): S31-8 (2010)

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.
[15671918] Diabetes Metab 30(6): 487-96 (2004)

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.
[15671919] Diabetes Metab 30(6): 498-505 (2004)

Pancreatic alpha-cell dysfunction in diabetes.
[18640586] Diabetes Metab 34 Suppl 2(-): S49-55 (2008)

Recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes. Consensus document.
[21270909] Nefrologia 31(1): 17-26 (2011)

Rapid onset of coma and death in the initial presentation of type 2 diabetes in an 11-year-old child.
[19030339] Paediatr Child Health 12(1): 41-2 (2007)

Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes.
[18212763] Nat Clin Pract Endocrinol Metab 4(3): 164-72 (2008)

2011 clinical practice guidelines for type 2 diabetes in Korea.
[22111032] Diabetes Metab J 35(5): 431-6 (2011)

Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies.
[19801365] J Am Pharm Assoc (2003) 49 Suppl 1(-): S3-9 (2009)

IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes.
[19429674] J Mol Endocrinol 43(5): 187-95 (2009)

Prevention and treatment of type 2 diabetes in youth.
[17008794] Horm Res 67(1): 22-34 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus T2DM (Type2).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Diabetes mellitus T2DM (Type2).php on line 92